Journal article
ABVD versus BEACOPP for Hodgkin's lymphoma
CS Tam, A Herschtal, JF Seymour
New England Journal of Medicine | MASSACHUSETTS MEDICAL SOC | Published : 2011
DOI: 10.1056/NEJMc1109618
Abstract
To the Editor: Viviani and colleagues (July 21 issue)1 compared the ABVD regimen (doxorubicin, bleomycin, vinblastine, and dacarbazine) with an escalated BEACOPP regimen (bleomycin, etoposide, doxo...